Tetraphase Pharma (TTPH) Announced Clinical Data from Oral Eravacycline Development Program
Tweet Send to a Friend
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) today announced the presentation of data at IDWeek 2017 from the first study of a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
